Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells

International Immunopharmacology

Volumn 8, Issue 12, 2008, Pages 1672-1680

  Nicolis, Elena ^a   Lampronti, Ilaria ^b   Dechecchi, Maria Cristina ^a   Borgatti, Monica ^b   Tamanini, Anna ^a   Bianchi, Nicoletta ^b   Bezzerri, Valentino ^a   Mancini, Irene ^b   Grazia Giri, Maria ^a   Rizzotti, Paolo ^a   Gambari, Roberto ^b   Cabrini, Giulio ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b ER GenTech   (Italy)

Author keywords

Cystic fibrosis; Cytokine; Emblica officinalis; Inflammation; Pseudomonas aeruginosa; Pyrogallol

Indexed keywords

5 HYDROXYISOQUINOLINE; EMBLICA OFFICINALIS EXTRACT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; ISOQUINOLINE DERIVATIVE; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; PYROGALLOL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CYTOKINE RELEASE; DRUG EFFECT; EMBLICA OFFICINALIS; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-INFLAMMATORY AGENTS; BRONCHI; CELLS, CULTURED; CHEMOKINE CXCL1; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; PHYLLANTHUS EMBLICA; PYROGALLOL;

EID: 54549123494     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.08.001     Document Type: Article

References (31)

1. Welsh J.M., Ramsey B.W., Accurso F., and Cutting G.R. The metabolic and molecular bases of inherited diseases (2001), New York, McGraw-Hill
2. Tirouvanziam R., Khazaal I., and Peault B. Primary inflammation in human cystic fibrosis small airways. Am J Physiol Lung Cell Mol Physiol 283 (2002) L445-L451
3. Scheid P., Kempster L., Griesenbach U., Davies J.C., Dewar A., Weber P.P., et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 17 (2001) 27-35
4. Chmiel J.F., and Davis P.B. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection. Respir Res 4 (2003) 8
5. Schmidt B.M., Ribnicky D.M., Lipsky P.E., and Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 3 (2007) 360-366
6. Ahmad I., Mehmood Z., and Mohammad F. Screening of some Indian medicinal plants for their antimicrobial propertioes. J Ethnopharmacol 62 (1998) 183-193
7. Datta B.K., Rahman I., and Das T.K. Antifungal activity of Indian plant extracts. Mycoses 41 (1998) 535-536
8. K han M.T., A A., ther, T K.D., hompson, G R., and ambari. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res 67 (2005) 107-119
9. Jose J.K., Kuttan G., and Kuttan K. Antitumour activity of Emblica officinalis. J Ethnopharmacol 75 (2001) 65-69
10. L ampronti I., M D., artello, B N., ianchi, B M., orgatti, L E., ambertini, P R., iva, et al. In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa. Phytomedicine 10 (2003) 300-308
11. L ambertini E., P R., iva, K M.T., han, L I., ampronti, B N., ianchi, B M., orgatti, et al. Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene. Int J Oncol 24 (2004) 419-423
12. Brinker A.M., Ma J., Lipsky P.E., and Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68 (2007) 732-766
13. Cardini F., Wade C., Regalia A.L., Gui S., Li W., Raschetti R., et al. Clinical research in traditional medicine: priorities and methods. Complement Ther Med 14 (2006) 282-287
14. Bhattacharya A., Chatterjee A., Ghosal S., and Bhattacharya S.K. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 37 (1999) 676-680
15. Lampronti I, Khan MTH, Borgatti M, Bianchi N, Gambari R, Inhibitory effects of Bangladeshi medicinal plant extracts on interactions between transcription factors and target DNA sequences. eCAM Advanced Access 2007.
16. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., et al. The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 (2004) 280-288
17. Jones A.M., Martin L., Bright-Thomas R.J., Dodd M.E., McDowell A., Moffitt K.L., et al. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. Eur. Respir. J 22 (2003) 503-506
18. Koehler D.R., Downey G.P., Sweezey N.B., Tanswell A.K., and Hu J. therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 31 (2004) 377-381
19. Zeitlin P.L., Lu L., Rhim J., Cutting G., Stetten G., Kieffer K.A., et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 14 (1991) 313-319
20. Dechecchi M.C., Nicolis E., Bezzerri V., Vella A., Colombatti M., Assael B.M., et al. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am J Respir Cell Mol Biol 36 (2007) 615-624
21. Kahn M.T.H., Lampronti I., Martello D., Bianchi N., Jabbar S., Choudhuri M.S.K., et al. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumore cell lines. Int J Onc 20 (2002) 187-192
22. Tomkins B.A., and Sega G.A. Determination of thiodyglycol in groundwater using solid-phase extraction followed by gas chromatography with mass spectrometric detection in the selected-ion mode. J Chromatogr A 909 (2001) 13-28
23. Tamanini A., Nicolis E., Bonizzato A., Bezzerri V., Melotti P., Assael B.M., et al. Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J Virol 80 (2006) 11241-11254
24. Saiman L., and Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 92 (1993) 1875-1880
25. Koehn F.E., and Carter G.T. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4 (2005) 206-220
26. Perianayagam J.B., Sharma S.K., Joseph A., and Christina A.J. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol 95 (2004) 83-85
27. Scartezzini P., and Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 71 (2000) 23-43
28. Han Y.H., Kim S.Z., Kim S.H., and Park W.H. Pyrogallol as a glutathione depletor induces apoptosis in HeLa cells. Int J Mol Med 21 (2008) 721-730
29. Han Y.H., Kim S.Z., Kim S.H., and Park W.H. Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 59 (2008) 301-314
30. Esberg L.B., and Ren J. The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway: protection by anisodamine and tetramethylpyrazine. Cardiovasc Toxicol 4 (2004) 375-384
31. Bals R., and Hiemstra P.S. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 23 (2004) 327-333